FOCUS: Biosciences institute’s chief scientific officer aims to foster commercialization
Rainer Fischer’s goal is to spur collaboration in research and commercialization of life sciences products.
Rainer Fischer’s goal is to spur collaboration in research and commercialization of life sciences products.
Two Indianapolis-based subsidiaries of Swiss pharmaceutical giant Roche Group are accusing a group of pharmacies and supply houses of engaging in an elaborate scheme to defraud Roche of millions of dollars worth of sales on diabetes test strips.
As Republicans pushed to end the Affordable Care Act, nearly 22,000 fewer Hoosiers bought health coverage on the exchanges, a decline some say could hurt hospitals.
The expansion at the Lilly Technology Center southwest of downtown is part of an $850 million investment the company is making this year in its U.S. research labs, manufacturing plants and other operations.
Breg Inc. will continue to supply thousands of orthopedic surgeons from operations in Indianapolis after relocating to a facility near the airport.
Dave Ricks joined Lilly in 1996 and most recently served as president of Lilly Bio-Medicines. He took over as president and CEO on Jan. 1.
In hospitals and clinics around Indiana, specialized nurses with advanced degrees and extensive training are booming in numbers.
Taltz, which hit the market last year, is taking on an armful of older treatments, including creams, lotions, pills and injectables, such as Amgen’s Enbrel and AbbVie’s Humira.
The Swiss-based company confirmed Wednesday morning the cuts are part of a U.S. restructuring that will result in eliminating 133 full-time workers and 24 contractors.
Divesting three hospitals in northern Indiana pushed down earnings, but revenue and occupancy didn’t skip a beat in 2016 at the state's largest health system.
The hospital system plans to tear down a two-story hotel near its Indianapolis flagship campus and build a training facility for simulating situations in acute care.
Getting elected mayor requires fine-tuned political instincts. Sometimes, those instincts say it’s time to leave a high-level job at the biggest company in town.
Just when I thought getting through chemo was a tough challenge, I faced another—six days in the hospital to remove and replace my cancerous bladder. I hope the lessons I learned will make me a better journalist.
For years, medical-device makers in Indiana and around the nation have insisted that the 2.3 percent tax on sales to help fund the Affordable Care Act has hurt business and slowed innovation.
The company’s quarterly earnings announcement did not mention any new developments in the insurer’s pending, $54 billion acquisition of Cigna—which is under review by a federal judge.
The Indianapolis-based drugmaker got a revenue boost from a host of new medications but also saw sales fall sharply for some older products.
Indiana now has one of the lowest cigarette taxes in the nation. It also has one of the highest smoking rates. Some groups want to decrease the latter in part by raising the former.
The number of transplants performed in Indiana last year hit an 11-year high, up about 6 percent from a year before, according to the Organ Procurement and Transplantation Network.
Planned Parenthood of Indiana and Kentucky Inc. is searching for a new president and CEO to succeed Betty Cockrum, who plans to retire in June.
The drug industry spends $5 billion a year pitching its pills and ointments to consumers. But it still finds itself on the defensive over high prices, so an industry group is trying to rescue its image.